FindTrial
Sign In

A clinical study to see how good is Immature Granulocyte Count (a blood test report) for early prediction of severe disease in ICU patients that can lead to Sepsis( a severe form of life threatening illness)

Evaluation of Immature Granulocyte Count as early marker of sepsis: a Prospective Observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064782
Enrollment
91
Registered
2024-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Shabnam Ahmeda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to ICU with a clinical suspicion of infection based on SIRS criteria

Exclusion criteria

Exclusion criteria: 1. Patients with blood malignancy 2. Patients with immunodeficiency disease 3. Patients those being treated with immunosupressive medication 4. Patients who develop sepsis and expired within 24 hours of beginning of study 5. Pregnant patients

Design outcomes

Primary

MeasureTime frame
To evaluate Immature Granulocyte Count and Immature Granulocyte percentage as one of the early biomarker of sepsisTimepoint: Will be done on Day 0 of admission as baseline and on days 1, 3 after admisssion—

Secondary

MeasureTime frame
To compare Immature Granulocyte Count and Immature Granulocyte percentage with SOFA Score in predicting severity of sepsisTimepoint: Will be done Days 1 and 3 of admission—

Countries

India

Contacts

Public ContactDr Shabnam Ahmeda

Gauhati Medical College and Hospital

sahariahiranya@gmail.com9435087643

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026